HLA-DRB1 AND THE DEVELOPMENT OF ANTIBODIES TO INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE

(1) KU Leuven



This item was part of the IBD II session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A361

You may be interested in:

PROTEIN CARBONYLATION PROFILE IN PATIENTS WITH ULCERATIVE COLITIS: A COMPARATIVE PROTEOMIC STUDY
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATE TO SEVERELY ACTIVE ULCERATIVE COLITIS
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
ATG16L1 GENOTYPE IS ASSOCIATED WITH RESPONSE TO ANTI-TNF
English, Genetics, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Disease
    • Inflammatory bowel disease
  • Disease Feature
    • Genetics
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013